InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Greenwich LifeSciences, Inc.

GLSI Clue Score23
United States Fiscal year ends December CIK 0001799788
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Snehal Patel
29 Jul 2026
CEO and CFO
Buy
700
$13.10
$9.17K
Snehal Patel
28 Jul 2026
CEO and CFO
Buy
1,500
$13.59
$20.39K
Snehal Patel
27 Jul 2026
CEO and CFO
Buy
1,500
$13.62
$20.43K
Snehal Patel
24 Jul 2026
CEO and CFO
Buy
1,100
$12.88
$14.17K
Snehal Patel
23 Jul 2026
CEO and CFO
Buy
2,500
$13.14
$32.85K
Snehal Patel
13 Jan 2026
CEO and CFO
Buy
1,800
$29.83
$53.69K
Snehal Patel
12 Jan 2026
CEO and CFO
Buy
2,900
$27.54
$79.87K
Snehal Patel
31 Dec 2025
CEO and CFO
Buy
4,300
$21.36
$91.85K
Snehal Patel
30 Dec 2025
CEO and CFO
Buy
2,900
$21.73
$63.02K
Snehal Patel
18 Dec 2025
CEO and CFO
Buy
4,100
$12.62
$51.74K
Snehal Patel
25 Nov 2025
CEO and CFO
Buy
4,600
$8.37
$38.50K
Snehal Patel
7 Nov 2025
CEO and CFO
Buy
10,600
$8.43
$89.36K
Show all 12 transactions →

What was left out

Form 4 filings counted 11
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 29 Sep 2020